These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2173739)
1. Human monoclonal antibodies to human cytomegalovirus derived from peripheral blood lymphocytes of healthy adults. Kitamura K; Yamada K; Kuzushima K; Morishima T; Morishima Y; Yamamoto N; Nishiyama Y; Ohya K; Yamaguchi H J Med Virol; 1990 Sep; 32(1):60-6. PubMed ID: 2173739 [TBL] [Abstract][Full Text] [Related]
2. Human monoclonal antibodies recognize early and late viral proteins of human cytomegalovirus. Alexander H; Harpprecht J; Podzuweit HG; Rautenberg P; Müller-Ruchholtz W Hum Antibodies Hybridomas; 1994; 5(1-2):81-90. PubMed ID: 7858186 [TBL] [Abstract][Full Text] [Related]
3. Human monoclonal antibodies to human cytomegalovirus. Foung SK; Perkins S; Bradshaw P; Rowe J; Rabin LB; Reyes GR; Lennette ET J Infect Dis; 1989 Mar; 159(3):436-43. PubMed ID: 2536787 [TBL] [Abstract][Full Text] [Related]
4. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. Yu X; McGraw PA; House FS; Crowe JE J Immunol Methods; 2008 Jul; 336(2):142-51. PubMed ID: 18514220 [TBL] [Abstract][Full Text] [Related]
5. Efficient generation of human anti-cytomegalovirus IgG monoclonal antibodies from preselected antigen-specific B cells. Steenbakkers PG; Van Wezenbeek PM; van Zanten J; The TH Hum Antibodies Hybridomas; 1993 Oct; 4(4):166-73. PubMed ID: 7504956 [TBL] [Abstract][Full Text] [Related]
7. Production of human monoclonal IgG antibodies reacting with cytomegalovirus (CMV). Bron D; Delforge A; Lagneaux L; De Martynoff G; Bosmans E; Van der Auwera P; Snoeck R; Burny A; Stryckmans P J Immunol Methods; 1990 Jul; 130(2):209-16. PubMed ID: 2165098 [TBL] [Abstract][Full Text] [Related]
8. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells. Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436 [TBL] [Abstract][Full Text] [Related]
9. Production of human monoclonal antibody to X31 influenza virus nucleoprotein. Crawford DH; Callard RE; Muggeridge MI; Mitchell DM; Zanders ED; Beverley PC J Gen Virol; 1983 Mar; 64 Pt 3():697-700. PubMed ID: 6298350 [TBL] [Abstract][Full Text] [Related]
10. Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells. Funaro A; Gribaudo G; Luganini A; Ortolan E; Lo Buono N; Vicenzi E; Cassetta L; Landolfo S; Buick R; Falciola L; Murphy M; Garotta G; Malavasi F BMC Biotechnol; 2008 Nov; 8():85. PubMed ID: 19014469 [TBL] [Abstract][Full Text] [Related]
11. Further analyses of epitopes for human monoclonal anti-basement membrane zone antibodies produced by stable human hybridoma cell lines constructed with Epstein-Barr virus transformants. Hashimoto T; Amagai M; Ebihara T; Gamou S; Shimizu N; Tsubata T; Hasegawa A; Miki K; Nishikawa T J Invest Dermatol; 1993 Mar; 100(3):310-5. PubMed ID: 7680057 [TBL] [Abstract][Full Text] [Related]
12. The selection and characterization of human monoclonal antibodies to human cytomegalovirus. Redmond MJ; Leyritz-Wills M; Winger L; Scraba DG J Virol Methods; 1986 Aug; 14(1):9-24. PubMed ID: 3021800 [TBL] [Abstract][Full Text] [Related]
13. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus. Gustafsson B; Jondal M; Sundqvist VA Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784 [TBL] [Abstract][Full Text] [Related]
14. Human monoclonal antibodies isolated from spontaneous Epstein-Barr virus-transformed tumors of Hu-SPL-SCID mice and specific for fusion protein display broad neutralizing activity toward respiratory syncytial virus. Chamat S; Walsh EE; Anderson D; Osta M; Awaraji C; Pan LZ; Ochi J; Shuey S; Brams P J Infect Dis; 1999 Aug; 180(2):268-77. PubMed ID: 10395839 [TBL] [Abstract][Full Text] [Related]
15. Characterization of human monoclonal antibodies directed against the pp65-kD matrix antigen of human cytomegalovirus. Ohlin M; Sundqvist VA; Gilljam G; Rudén U; Gombert FO; Wahren B; Borrebaeck CA Clin Exp Immunol; 1991 Jun; 84(3):508-14. PubMed ID: 1710548 [TBL] [Abstract][Full Text] [Related]
16. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. Buchacher A; Predl R; Strutzenberger K; Steinfellner W; Trkola A; Purtscher M; Gruber G; Tauer C; Steindl F; Jungbauer A AIDS Res Hum Retroviruses; 1994 Apr; 10(4):359-69. PubMed ID: 7520721 [TBL] [Abstract][Full Text] [Related]
17. The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus. Grunow R; Jahn S; Porstmann T; Kiessig SS; Steinkellner H; Steindl F; Mattanovich D; Gürtler L; Deinhardt F; Katinger H J Immunol Methods; 1988 Feb; 106(2):257-65. PubMed ID: 2828478 [TBL] [Abstract][Full Text] [Related]
18. Specific IgM response and characteristics of the lymphoblastoid cell lines obtained from an infant with probable mixed cytomegalovirus and Epstein-Barr virus infection. Joncas JH; Menezes J; Lussier G IARC Sci Publ (1971); 1975; (11 Pt 2):283-9. PubMed ID: 191372 [No Abstract] [Full Text] [Related]
19. Human monoclonal antibodies neutralizing human cytomegalovirus. Masuho Y; Matsumoto Y; Sugano T; Fujinaga S; Minamishima Y J Gen Virol; 1987 May; 68 ( Pt 5)():1457-61. PubMed ID: 2437245 [TBL] [Abstract][Full Text] [Related]
20. Production of anti-tumor human monoclonal antibodies using different approaches. Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]